Skip to header Skip to main navigation Skip to main content Skip to footer
Home
Academic Citations from Palestine
Foregrounding the Research of Academics in Palestine

Main navigation

  • Home
  • Search
  • About

Molecular toxicological alterations in the mouse hearts induced by sub-chronic thiazolidinedione drugs administration

Blank
Israa University
Jarrar Y.B.; Jarrar Q.; Abaalkhail S.J.; Moh'd Kalloush H.; Naser W.; Zihlif M.; Al Shhab M.; El Madani A.; Jamous Y.; Lee S.-J.
Jarrar, Yazun Bashir (57070259300); Jarrar, Qais (56786465300); Abaalkhail, Sara J. (57221356659); Moh'd Kalloush, Hanin (57223841194); Naser, Wisam (57194324826); Zihlif, Malek (35084748900); Al Shhab, Mohammad (57205392287); El Madani, Abdulla (58608903700); Jamous, Yahya (57207689576); Lee, Su-Jun (23015677000)
57070259300; 56786465300; 57221356659; 57223841194; 57194324826; 35084748900; 57205392287; 58608903700; 57207689576; 23015677000
2022
Fundamental and Clinical Pharmacology
Molecular toxicological alterations in the mouse hearts induced by sub-chronic thiazolidinedione drugs administration
36
1
143
149
John Wiley and Sons Inc
Department of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan; Department of Pharmaceutical Science, Al-Isra'a University, Amman, Jordan; Department of Pharmacology, Faculty of Medicine, The University of Jordan, Amman, Jordan; Nanotechnology Centre, King AbdulAziz City of Science and Technology, Riyadh, Saudi Arabia; Department of Pharmacology, College of Medicine, Inje University, Busan, South Korea
Jarrar Y.B., Department of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan; Jarrar Q., Department of Pharmaceutical Science, Al-Isra'a University, Amman, Jordan; Abaalkhail S.J., Department of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan; Moh'd Kalloush H., Department of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan; Naser W., Department of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan; Zihlif M., Department of Pharmacology, Faculty of Medicine, The University of Jordan, Amman, Jordan; Al Shhab M., Department of Pharmacology, Faculty of Medicine, The University of Jordan, Amman, Jordan; El Madani A., Department of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan; Jamous Y., Nanotechnology Centre, King AbdulAziz City of Science and Technology, Riyadh, Saudi Arabia; Lee S.-J., Department of Pharmacology, College of Medicine, Inje University, Busan, South Korea
Y.B. Jarrar; Department of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan; email: yazun.jarrar@zuj.edu.jo
7
10.1111/fcp.12694
Animals; Glycoproteins; Hypoglycemic Agents; Mice; Pharmaceutical Preparations; Phosphoproteins; Rosiglitazone; Thiazolidinediones; 2,4 thiazolidinedione derivative; 20 hydroxyicosatetraenoic acid; branched chain amino acid; chemokine receptor CCR1; cytochrome P450; cytochrome P450 1A1; cytochrome P450 4A12; glyceraldehyde 3 phosphate dehydrogenase; messenger RNA; metalloproteinase inhibitor; monocyte chemotactic protein 3; pioglitazone; rosiglitazone; unclassified drug; uncoupling protein 1; 2,4-thiazolidinedione; antidiabetic agent; Bpifa1 protein, mouse; drug; glycoprotein; phosphoprotein; animal experiment; animal model; Article; body weight; cardiotoxicity; controlled study; down regulation; heart weight; male; mouse; mRNA expression level; nonhuman; real time polymerase chain reaction; RNA extraction; upregulation; animal